ResearcherStavanger University HospitalActive in the last 2 years
Hanne Røland Hagland
Matched on ORCID iD 0000-0002-7470-1358; OpenAlex author ID A5062697686. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-naïve periampullary tumors. Co-author DOI 10.1016/j.pan.2024.12.018↗
- Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinic… Last author DOI 10.1002/cam4.7318↗
- Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic duct… Last author DOI 10.1186/s40170-022-00285-w↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kjetil Søreide · 3 shared papers, 2022–2025 · strength 0.75
- Paper Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting v… DOI 10.1002/cam4.7318↗
- Paper Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-… DOI 10.1016/j.pan.2024.12.018↗
- Paper Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures … DOI 10.1186/s40170-022-00285-w↗
- Tia Tidwell · 2 shared papers, 2022–2024 · strength 0.48
- Paper Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting v… DOI 10.1002/cam4.7318↗
- Paper Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures … DOI 10.1186/s40170-022-00285-w↗
- Marcus T. T. Roalsø · 1 shared paper, 2025 · strength 0.27
- Claudia Zaharia · 1 shared paper, 2025 · strength 0.27
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.